Procter & Gamble (NYSE:PG) PT Raised to $170.00 at Barclays

Procter & Gamble (NYSE:PG) had its price objective hoisted by Barclays from $168.00 to $170.00 in a report released on Tuesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock.

A number of other equities research analysts also recently issued reports on PG. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an overweight rating on the stock in a report on Thursday, January 18th. Raymond James increased their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an outperform rating in a report on Wednesday, January 24th. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a hold rating in a report on Wednesday, January 24th. Truist Financial raised shares of Procter & Gamble from a hold rating to a buy rating and increased their price target for the stock from $160.00 to $175.00 in a report on Monday, March 11th. Finally, The Goldman Sachs Group started coverage on shares of Procter & Gamble in a report on Friday, March 1st. They issued a neutral rating and a $168.00 price target on the stock. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of Moderate Buy and an average price target of $169.76.

Procter & Gamble Price Performance

NYSE PG opened at $161.24 on Tuesday. The company has a market cap of $380.55 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 3.30 and a beta of 0.44. Procter & Gamble has a 52 week low of $141.45 and a 52 week high of $164.32. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The firm’s 50-day simple moving average is $159.64 and its two-hundred day simple moving average is $153.51.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company’s revenue was up .6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.37 earnings per share. Research analysts predict that Procter & Gamble will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 45,000 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the transaction, the chief executive officer now directly owns 973 shares in the company, valued at $151,788. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the transaction, the chief executive officer now directly owns 973 shares of the company’s stock, valued at $151,788. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 28,369 shares of Procter & Gamble stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the transaction, the insider now directly owns 11,507 shares in the company, valued at $1,858,265.43. The disclosure for this sale can be found here. Insiders have sold 100,865 shares of company stock worth $16,029,280 over the last ninety days. Insiders own 0.17% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Advantage Trust Co purchased a new position in shares of Procter & Gamble in the fourth quarter worth $28,000. Wyrmwood Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $29,000. Naples Money Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $29,000. Transcendent Capital Group LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $31,000. Finally, Criterion Capital Advisors LLC bought a new stake in Procter & Gamble in the fourth quarter valued at $33,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.